Skip to content
drillr.ai
Sign up

600867.SH

Tonghua Dongbao Pharmaceutical Co., Ltd.

SSE · Healthcare · Drug Manufacturers - General · CN

CNY 7.57
−1.05%
Ask drillr

  • Oct 22, 2026, 11:21 UTC

    Tonghua Dongbao Pharmaceutical, a shareholder holding more than 5% of Tecon Biology, committed not to reduce its directly held shares for two years.

    Source:

  • Sep 28, 2026, 09:26 UTC

    Tonghua Dongbao's controlling shareholder Dongbao Group released a pledge on 14 million shares on September 23, 2026, and re-pledged the same 14 million shares on September 24, 2026 to China Construction Bank Tonghua Branch to repay debt, with the pledge maturing on September 23, 2027.

    Source:

  • Aug 24, 2026, 09:18 UTC

    Tonghua Dongbao announced its first-half 2026 results: net profit attributable to shareholders was 296 million yuan, up 37.32% year-on-year, with revenue of 1.553 billion yuan, up 11.13%.

    Source:

  • Aug 11, 2026, 07:39 UTC

    Tonghua Dongbao subscribed to 1.62 million convertible bonds issued by Tebao Bio for 162 million yuan, which were fully allocated and will be listed on the Shanghai Stock Exchange on August 13, 2026.

    Source: